CD38+ cells pre-incubated with anti-CD31 monoclonal antibody or 8-Br-ADPR could both abrogate CD31 binding to CD38 and block CLL chemotaxis and homing via Ca2+ fluxes mediated by TRPM2 [40]. This evidence concerns the gene TRPM2 and B-cell chronic lymphocytic leukemia.